852110-52-2

Basic information

• Product Name: (7-bromo-2,3-dihydro-1-benzofuran-2-yl)methyl-4-methylbenzenesulfonate
• CAS NO: 852110-52-2
• Molecular Weight: 383.263
• Mol File: 852110-52-2.mol

Chemical Properties

• CAS DataBase Reference: (7-bromo-2,3-dihydro-1-benzofuran-2-yl)methyl-4-methylbenzenesulfonate(CAS DataBase Reference)
• NIST Chemistry Reference: (7-bromo-2,3-dihydro-1-benzofuran-2-yl)methyl-4-methylbenzenesulfonate(852110-52-2)
• EPA Substance Registry System: (7-bromo-2,3-dihydro-1-benzofuran-2-yl)methyl-4-methylbenzenesulfonate(852110-52-2)

Safety Data

• Hazardous Substances Data: 852110-52-2(Hazardous Substances Data)

Upstream product

• 17269-81-7 2-bromo-6-(2-propenyl)phenol 
• 60333-75-7 O-allyl-2-bromophenol 
• 95-56-7 2-hydroxybromobenzene 
• 852110-51-1 7-bromo-2-hydroxymethyl-2,3-dihydrobenzo[b]furan 
• 98-59-9 p-toluenesulfonyl chloride 

Downstream Products

• 852114-81-9 (+/-)-{[7-(5-chloro-2-methylphenyl)-2,3-dihydro-1-benzofuran-2-yl]methyl}amine 
• 852121-48-3 (+/-)-{[7-(2,5-dimethoxyphenyl)-2,3-dihydro-1-benzofuran-2-yl]methyl}amine 
• 852121-46-1 (+/-)-{[7-(2,5-dimethylphenyl)-2,3-dihydro-1-benzofuran-2-yl]methyl}amine 

Relevant articles and documents

Synthesis and biological evaluation of novel n-[(7-pyridin-4-yl-2, 3-dihydro-benzofuran-2-yl) methyl]-(4-methyl-1, 2, 3-thiadiazole-5-yl) formamide as a potent immunosuppressant agent

N-[(7-pyridin-4-yl-2, 3-dihydro-benzofuran-2-yl) methyl]-(4-methyl-1, 2, 3-thiadiazole-5-yl)-Formamide (1) was synthesized and its immunosuppressive activity was evaluated. The results showed it had highly immunosuppressive activity and can be studied as lead compound in the development of immunosuppressant agent.

DIHYDROBENZOFURANYL ALKANAMINE DERIVATIVES AS 5HT2C AGONISTS

Compounds of Formula (I) or pharmaceutically acceptable salts thereof are provided: Formula (I) which are agonists or partial agonists of the 2C subtype of brain serotonin receptors. The compounds, and compositions containing the compounds, can be used to treat a variety of central nervous system disorders such as schizophrenia.